Justine Naessens

Justine Naessens advises clients on EU and national regulatory matters in the life sciences area, including biotechnology, pharmaceuticals, medical devices, food and cosmetics, technology, and ESG (environmental, social, and governance).

Justine assists companies in the entire life cycle of products from early development stages to manufacturing, marketing, post-marketing, and pricing and reimbursement issues, as well as in M&A and other corporate transactions. Her legal studies included a concentration in technology, intellectual property, and medical law. Justine often assists clients in connection with regulatory matters involving the use of digital technologies in the health care sector, such as the classification of software as a medical device, the use of artificial intelligence (AI) in product development, and associated privacy (General Data Protection Regulation [GDPR]) requirements. She also has extensive experience advising life sciences clients on ESG matters, including compliance with the European Union Corporate Sustainability Reporting Directive (CSRD), Corporate Sustainability Due Diligence Directive (CSDDD), and the Deforestation Regulation.